Saxagliptin, in combination with metformin, provides a durable, well-tolerated, and cost-effective treatment option for patients with type 2 diabetes mellitus, from a US payer perspective.
Joette Gdovin Bergeson, PhD
Advertisement
Articles by Joette Gdovin Bergeson, PhD
Advertisement
Latest Updated Articles
- US Cost-Effectiveness of Saxagliptin in Type 2 Diabetes Mellitus
February 10th 2012
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves mFlusiva, the First mRNA-Based Influenza Vaccine
2
The Side Door We Could Close: A Pharmacy Perspective on Menopause, Access, and the Leadership Pipeline
3
Study Reveals a Widening Gap Between Buprenorphine Prescribing and Dispensing
4
CVS Health Expands GLP-1 Access With $29 Visits, Lilly Deal
5